Disperazol Pharma ApS — Credit Rating and Financial Key Figures

Disperazol Pharma ApS (CVR number: 44265761) is a company from FREDENSBORG. The company recorded a gross profit of 40.5 kDKK in 2024. The operating profit was 40.5 kDKK, while net earnings were 31.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was 50.6 %, which can be considered excellent and Return on Equity (ROE) was 44.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 88.9 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Disperazol Pharma ApS's liquidity measured by quick ratio was 9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.